Entera Bio enters into $5M ATM equity facility with SVB; terminates prior B. Riley ATM

Entera Bio Ltd.

Entered Sales Agreement with SVB Securities for at-the-market offering of up to 5,000,000 ordinary shares.
Agent commission set at 3.0% of gross sales price per ordinary share sold.
Prior B. Riley Securities ATM terminated effective Aug 30, 2022; no shares were sold under it.
Net proceeds planned for general corporate purposes including R&D, clinical trials, and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.